Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
PrediSurge logo — Precision Medicine Platform for Cardiovascular Interventions

PrediSurge

Precision Medicine Platform for Cardiovascular Interventions

Founded 2017 France France 34 employees Series A Total: $10.50M Health Care, Information Technology +1

General Information

Company Name PrediSurge
Founded Year 2017
Location France France +1
Employees 34
Industries Health Care, Information Technology, Medical Devices
Funding Stage Series A
Social

Get notified when PrediSurge moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About PrediSurge

PrediSurge is a precision medicine platform that offers a novel approach for cardiovascular interventions. Founded in 2017, the company's technology leverages pre-operative imaging to create patient-specific digital twins, enabling physicians to simulate arteries and valves' biomechanical behavior. These digital models are valuable in both clinical and industrial contexts, allowing for the investigation of different device implantation approaches and aiding in the early de-risking of medical device designs. The recent €6.50M Series A investment in October 16, 2023 saw participation from prominent investors including European Innovation Council, LIFTT, UI Investissement, Saint Victor Capital, and Crédit Agricole Lhl Capital Innovation. PrediSurge's innovative technology not only enhances procedure planning and medical device design but ultimately strives to make endovascular procedures safer for patients. Operating from its headquarters in France, PrediSurge stands at the forefront of healthcare, information technology, and medical devices industries, offering a promising investment opportunity.

Taxonomy: Precision Medicine, Cardiovascular Interventions, Digital Solutions, Numerical Simulation, Decision Support, Medical Device Design, Endovascular Repair, Biomechanical Modeling, Clinical Simulation, Digital Twin Technology, Medical Imaging Analysis

Services & Products

PrediSurge develops precision medicine platform for cardiovascular interventions
creating patient-specific digital twins for numerical models simulating the biomechanical behavior of arteries and cardiac valves.

Target Customers

The company's target customers and users include cardiovascular physicians clinical specialists and medical device companies seeking advanced tools for risk assessment and precision in endovascular procedures.

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 5
Investor Investor Investor
•••• •••• 		16 Oct 2023
Venture Round •••••• 1
Investor
23 Mar 2022
Grant •••••• 1
Investor
23 Mar 2022
Seed Round •••••• - 01 Jan 2020

PrediSurge Alternatives & Competitors

PrediSurge vs
InSilicoTrials
InSilicoTrials United States

Innovating Life Sciences

Series A
28 employees
Compare PrediSurge vs InSilicoTrials
PrediSurge vs
Ebenbuild
Ebenbuild Germany

Personalized health intelligence for the lung

Unknown
30 employees
Health Care, Medical Devices
Compare PrediSurge vs Ebenbuild
PrediSurge vs
Simbionix
Simbionix

Empowering medical professionals with advanced simulation and personalized training solutions to ele...

Series Unknown
Education, Health Care
Compare PrediSurge vs Simbionix

FAQ About PrediSurge

Precision Medicine Platform for Cardiovascular Interventions
PrediSurge was founded in 2017.
PrediSurge is headquartered in France.
PrediSurge operates in the following industries: Health Care, Information Technology, Medical Devices.
PrediSurge has approximately 34 employees.
PrediSurge has completed 4 funding rounds, raising a total of $10.50M. The latest funding stage is Series A.
PrediSurge offers: PrediSurge develops precision medicine platform for cardiovascular interventions, creating patient-specific digital twins for numerical models simulating the biomechanical behavior of arteries and cardiac valves..
Top alternatives and competitors to PrediSurge include InSilicoTrials, Ebenbuild, Simbionix, Elucid Labs, Infuse Med - Digital Production Agency. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PrediSurge and InSilicoTrials are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PrediSurge and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes